Cargando…
Transarterial embolisation of hepatocellular carcinoma with doxorubicin-eluting beads: single centre early experience
PURPOSE: This is a retrospective study to evaluate the results of our early experience of using doxorubicin eluting beads (DEB) to treat patients with early and intermediate hepatocellular carcinoma (HCC). Material and methods: A cohort of 19 patients (84.2% male; 15.8% female; mean age 59.2 years ±...
Autores principales: | Nawawi, O, Hazman, MN, Abdullah, BJJ, Vijayananthan, A, Manikam, J, Mahadeva, S, Goh, KL |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Malaysia
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097792/ https://www.ncbi.nlm.nih.gov/pubmed/21611067 http://dx.doi.org/10.2349/biij.6.1.e7 |
Ejemplares similares
-
Uterine artery embolisation for symptomatic fibroids: the University of Malaya Medical Centre experience
por: Subramaniam, RN, et al.
Publicado: (2010) -
Doxorubicin-loaded Drug-eluting beads Versus Conventional Transarterial Chemoembolization for Nonresectable Hepatocellular Carcinoma
por: Arabi, Mohammad, et al.
Publicado: (2015) -
Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma
por: Nam, Hee Chul, et al.
Publicado: (2016) -
Doxorubicin-loaded Drug-eluting beads Versus Conventional Transarterial Chemoembolization for Nonresectable Hepatocellular Carcinoma: Erratum
Publicado: (2015) -
Conventional vs drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma
por: Song, Jeong Eun, et al.
Publicado: (2017)